Your browser doesn't support javascript.
loading
Development of a low-seroprevalence, αvß6 integrin-selective virotherapy based on human adenovirus type 10.
Bates, Emily A; Davies, James A; Vánová, Jana; Nestic, Davor; Meniel, Valerie S; Koushyar, Sarah; Cunliffe, Tabitha G; Mundy, Rosie M; Moses, Elise; Uusi-Kerttula, Hanni K; Baker, Alexander T; Cole, David K; Majhen, Dragomira; Rizkallah, Pierre J; Phesse, Toby; Chester, John D; Parker, Alan L.
Affiliation
  • Bates EA; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Davies JA; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Vánová J; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Nestic D; Department of Genetics and Microbiology, Faculty of Science, Charles University, Vinicná 5, 128 44 Prague 2, Czech Republic.
  • Meniel VS; Division of Molecular Biology, Ruder Boskovic Institute, Bijenicka cesta 54, 10000 Zagreb, Croatia.
  • Koushyar S; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.
  • Cunliffe TG; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.
  • Mundy RM; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Moses E; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Uusi-Kerttula HK; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Baker AT; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Cole DK; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Majhen D; Division of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Rizkallah PJ; Division of Molecular Biology, Ruder Boskovic Institute, Bijenicka cesta 54, 10000 Zagreb, Croatia.
  • Phesse T; Division of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
  • Chester JD; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.
  • Parker AL; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
Mol Ther Oncolytics ; 25: 43-56, 2022 Jun 16.
Article de En | MEDLINE | ID: mdl-35399606
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Mol Ther Oncolytics Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Mol Ther Oncolytics Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique